Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · July 02, 2014

Empagliflozin Effective, Safe With Insulin for Inadequately Controlled Diabetes

Diabetes Care

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
Diabetes Care 2014 Jun 14;[EPub Ahead of Print], J Rosenstock, A Jelaska, G Frappin, A Salsali, G Kim, HJ Woerle, UC Broedl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading